AFT Pharmaceuticals

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.


Company Details

Registered Office: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Postal Address: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Telephone: +64 9 488 0232
Facsimile: n/a
Website: www.aftpharm.com
First Listed: 22/12/2015
Balance Date: 31 March
AGM: 01/08/2025

Directors and Executives

Hartley Atkinson
Executive Director
Marree Atkinson
Executive Director
David Flacks
Chairman
Andrew Lane
Director
Malcolm Tubby
CFO / Company Secretary
Ted Witek
Independent Non-Executive Director
Allison Yorston
Independent Director

Announcements

Title Date Type
Disclosure of Directors and Senior Managers Relevant Int Mon, Sep 01 2025 05:09 pm SHINTR
Results of 2025 Annual Shareholder Meeting Mon, Aug 04 2025 08:30 am GENERAL
2025 ASM Release, Chairs address & presentation Fri, Aug 01 2025 08:47 am GENERAL
Disclosure of Directors and Senior Managers Relevant Intere Fri, Jul 04 2025 08:30 am SHINTR
June Quarter FY 2026 Investor Update Tue, Jul 01 2025 08:35 am GENERAL
Disclosure of Directors and Senior Managers Relevant Intere Fri, Jun 27 2025 08:42 am SHINTR
Notice of Annual Meeting of Shareholders 2025 Fri, Jun 27 2025 08:39 am MEETING
Annual Meeting and Closing Date for Director Nominations Fri, May 30 2025 08:59 am MEETING
AFT and Hikma extend US Maxigesic Cooperation Mon, May 26 2025 08:38 am GENERAL
Corrected Distribution Notice Thu, May 22 2025 12:18 pm CORPACT

Major Holdings Announcements

Date Name No. Held % Current
07/11/24 Accident Compensation Corporation 7,523,033 6.05 7.17
16/09/20 Forsyth Barr Group Limited and Fors 1,617,818 71.25 1.55
15/06/20 Hartley Campbell Atkinson and Colin 72,031,609 72.60 69.82
15/06/20 The CRG Persons - 15.99 -
25/05/17 AFT Pharmaceuticals Limited - 72.34 -

Director’s Interests Announcements

Date Name No. Held % Details Other
01/09/25 David Flacks 196,486 - - -
04/07/25 Hartley Campbell Atkins 73,127,322 - - -
27/11/24 Andrew Lane 95,000 - - -
18/09/23 Jon Lamb 271,314 - - -
14/04/21 Malcolm Tubby 143,892 - - -
10/08/20 Hartley Atkinson 72,899,435 - - -
22/08/18 James Burns 125,417 - - -
19/06/17 John Douglas Wilson 56,689 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 04/09/2025


Markets News

Why does NZ suck at building brands
Markets

Eden Bradfield: Why does NZ suck at building brands

Let the French have Fonterra brands, Eden Bradfield writes.

Eden Bradfield 06 Sep 2025
Markets Market Close

NZ sharemarket ends week up 2.2%

The S&P/NZX 50 Index closed at 13,223.53, up 90.32 points or 0.69%.

Graham Skellern 05 Sep 2025
NZ sharemarket ends week up 2.2%
Markets

Fletcher Building slashes maximum CEO pay

 Total maximum remuneration is now $2m lower at $5.8m.

Rebecca Howard 05 Sep 2025
Fletcher Building slashes maximum CEO pay
Economy

Westpac NZ eyes monetary policy reform for change-laden RBNZ

Westpac NZ puts monetary policy voting in the spotlight.

Staff reporters 05 Sep 2025
Westpac NZ eyes monetary policy reform for change-laden RBNZ
Primary Sector

Miraka’s rapid sale illustrates David/Goliath dairy battle

Open Country’s buyout cements its place as NZ’s clear No 2 dairy processor.

Riley Kennedy 05 Sep 2025
Miraka’s rapid sale illustrates David/Goliath dairy battle